Last reviewed · How we verify
M1-c6v1
At a glance
| Generic name | M1-c6v1 |
|---|---|
| Sponsor | Guangzhou Virotech Pharmaceutical Co., Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors (PHASE1)
- IIT Study of M1-c6v1 Combined With SHR-1210 and Apatinib in Patients With HCC (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |